Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Pozzi

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
European Journal of Medicinal Chemistry|December 3, 2023
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agentsPasquale Linciano, Cecilia Pozzi, Giusy Tassone, et al.
Journal of Medicinal Chemistry|September 30, 2025
Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization ApproachJoanna Panecka-Hofman, Pasquale Linciano, Ina Pöhner, et al.
Journal of Medicinal Chemistry|November 26, 2019
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial InfectionsBin Liu, Robert E Lee Trout, Guo-Hua Chu, et al.
Journal of Medicinal Chemistry|June 8, 2022
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1Ina Pöhner, Antonio Quotadamo, Joanna Panecka-Hofman, et al.
European Journal of Medicinal Chemistry|September 4, 2025
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomicsLaura Scalvini, Lorenzo Tagliazucchi, Gian Marco Elisi, et al.
Molecules (Basel, Switzerland)|March 12, 2017
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic ActivityFlavio Di Pisa, Giacomo Landi, Lucia Dello Iacono, et al.
Chemmedchem|January 20, 2022
1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4 as VIM-type Metallo-β-Lactamase InhibitorsFederica Verdirosa, Laurent Gavara, Laurent Sevaille, et al.
European Journal of Medicinal Chemistry|September 16, 2020
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitorsLaurent Gavara, Laurent Sevaille, Filomena De Luca, et al.
Journal of Medicinal Chemistry|March 26, 2019
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic InfectionsPasquale Linciano, Cecilia Pozzi, Lucia Dello Iacono, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2011
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseDaniela Cardinale, Giambattista Guaitoli, Donatella Tondi, et al.
European Journal of Medicinal Chemistry|December 3, 2023
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agentsPasquale Linciano, Cecilia Pozzi, Giusy Tassone, et al.
Journal of Medicinal Chemistry|September 30, 2025
Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization ApproachJoanna Panecka-Hofman, Pasquale Linciano, Ina Pöhner, et al.
Journal of Medicinal Chemistry|November 26, 2019
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial InfectionsBin Liu, Robert E Lee Trout, Guo-Hua Chu, et al.
Journal of Medicinal Chemistry|June 8, 2022
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1Ina Pöhner, Antonio Quotadamo, Joanna Panecka-Hofman, et al.
European Journal of Medicinal Chemistry|September 4, 2025
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomicsLaura Scalvini, Lorenzo Tagliazucchi, Gian Marco Elisi, et al.
Molecules (Basel, Switzerland)|March 12, 2017
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic ActivityFlavio Di Pisa, Giacomo Landi, Lucia Dello Iacono, et al.
Chemmedchem|January 20, 2022
1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4 as VIM-type Metallo-β-Lactamase InhibitorsFederica Verdirosa, Laurent Gavara, Laurent Sevaille, et al.
European Journal of Medicinal Chemistry|September 16, 2020
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitorsLaurent Gavara, Laurent Sevaille, Filomena De Luca, et al.
Journal of Medicinal Chemistry|March 26, 2019
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic InfectionsPasquale Linciano, Cecilia Pozzi, Lucia Dello Iacono, et al.
Pageof 7